CN110105261A - A method of continuous, rapid synthesis and purification epiphysin using microreactor - Google Patents
A method of continuous, rapid synthesis and purification epiphysin using microreactor Download PDFInfo
- Publication number
- CN110105261A CN110105261A CN201811584073.4A CN201811584073A CN110105261A CN 110105261 A CN110105261 A CN 110105261A CN 201811584073 A CN201811584073 A CN 201811584073A CN 110105261 A CN110105261 A CN 110105261A
- Authority
- CN
- China
- Prior art keywords
- microreactor
- methoxytryptamine
- sodium carbonate
- solution
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 230000015572 biosynthetic process Effects 0.000 title abstract description 15
- 238000003786 synthesis reaction Methods 0.000 title abstract description 15
- 238000000746 purification Methods 0.000 title description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims abstract description 42
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000463 material Substances 0.000 claims abstract description 22
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- JTEJPPKMYBDEMY-UHFFFAOYSA-N 5-methoxytryptamine Chemical compound COC1=CC=C2NC=C(CCN)C2=C1 JTEJPPKMYBDEMY-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000000926 separation method Methods 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 229940097276 5-methoxytryptamine Drugs 0.000 claims abstract description 9
- 238000005292 vacuum distillation Methods 0.000 claims abstract description 6
- 239000012074 organic phase Substances 0.000 claims abstract description 4
- 238000001953 recrystallisation Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 26
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 claims description 16
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims description 16
- 229960003987 melatonin Drugs 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 13
- -1 5-methoxytryptamine-dichloromethane Chemical compound 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000004821 distillation Methods 0.000 claims description 8
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 1
- 230000032258 transport Effects 0.000 claims 1
- 239000012535 impurity Substances 0.000 abstract description 2
- 239000000376 reactant Substances 0.000 abstract description 2
- 238000005086 pumping Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 16
- 230000009286 beneficial effect Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000001427 coherent effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 238000011403 purification operation Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002090 nanochannel Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
Description
技术领域technical field
本发明涉及医药合成技术领域,具体涉及一种利用微反应器连续、快速合成及提纯褪黑素的方法。The invention relates to the technical field of medical synthesis, in particular to a method for continuously and rapidly synthesizing and purifying melatonin using a microreactor.
背景技术Background technique
褪黑激素(化学名N-乙酰基-5-甲氧基色胺)是人类大脑松果体分泌的一种吲哚类激素,其主要作用在于维护人体生理的昼夜节律,有利于睡眠,能够增强人体免疫功能,抑制肿瘤细胞的生长。褪黑素对中枢神经系统也有抑制作用,是一种比维生素E更有效的过氧化基清除剂,对人的生长发育、生殖功能和许多器官都能起调节作用。Melatonin (chemical name N-acetyl-5-methoxytryptamine) is an indole hormone secreted by the pineal gland of the human brain. Its main function is to maintain the circadian rhythm of human physiology, which is beneficial to sleep and can enhance Human immune function, inhibit the growth of tumor cells. Melatonin also has an inhibitory effect on the central nervous system. It is a more effective peroxide radical scavenger than vitamin E. It can regulate human growth and development, reproductive function and many organs.
微反应器又被称作微通道反应器,是一种新型的反应设备。微反应器通常含有当量直径且数量级介于微米和毫米之间的流体流动通道,化学反应就发生在这些通道中。随着技术的发展,微反应器越来越受到重视,相对于常规反应器,微反应器具有如下优点:Microreactor, also known as microchannel reactor, is a new type of reaction equipment. Microreactors typically contain fluid flow channels with equivalent diameters on the order of micrometers to millimeters in which chemical reactions take place. With the development of technology, more and more attention has been paid to microreactors. Compared with conventional reactors, microreactors have the following advantages:
1)反应时间可以精确控制。反应物在微反应器内连续流动过程中发生化学反应,通过控制物料停留时间可以精确反应时间;1) The reaction time can be precisely controlled. The reactant undergoes a chemical reaction during the continuous flow in the microreactor, and the reaction time can be accurately controlled by controlling the residence time of the material;
2)物料能够以精确比例瞬时混合。可以通过控制微反应器的反应参数,进而准确控制反应物料的精确比例;2) Materials can be mixed instantaneously in precise proportions. The precise ratio of reaction materials can be accurately controlled by controlling the reaction parameters of the microreactor;
3)实验结果易于放大。连续流动是微反应器技术最显著的一个特征,通过连续流动可以制备大量目标产物;3) The experimental results are easy to scale up. Continuous flow is the most notable feature of microreactor technology, and a large number of target products can be prepared through continuous flow;
4)安全性能高。可以在微反应器中安全的进行一些以往在常规条件下会发生爆炸的反应。4) High safety performance. Some reactions that used to be explosive under normal conditions can be safely carried out in microreactors.
尽管微反应器有诸多优点,但是其产物合成与分离提纯并不能同时进行,一般需要先在微反应器中合成产物并将其收集起来,然后将收集好的产物送入其他设备或后续工艺中进行提纯操作。现有微反应器产物的合成和提纯是分开的,整个工艺并不连贯,中间可能有停顿,整体生产效率较低。Although the microreactor has many advantages, its product synthesis and separation and purification cannot be carried out at the same time. Generally, it is necessary to synthesize the product in the microreactor and collect it, and then send the collected product to other equipment or subsequent processes. Carry out purification operation. The synthesis and purification of existing microreactor products are separated, the whole process is not coherent, there may be pauses in the middle, and the overall production efficiency is low.
当前已经有许多关于褪黑素合成工艺的报道。杨建武等(杨建武,曹会兰.褪黑激素的合成与表征[J].化学研究,2003,14(4):42-44.)报道了一种以5-甲氧基色胺为原料,乙酸酐为酰化试剂进行反应合成N-乙酰基-5-甲氧基色胺的方法,该方法存在酰化时间长(三个小时以上)、反应速度较慢、耗能大、成本高等问题,并不适合工业化生产。MiryamFemandez-Suarez等人(The development o f integrated microfluidic chemistryplatforms for lead optimization in the phar maceutical industry,Fourthinternational conference on Nanochannels,Microchann els and Minichannels,Miryam Femandez-Suarez,et al.,Page 1-6)公开了一种利用微反应器制备褪黑素的方法,其虽然使用微反应器将反应时间降到12s,但是合成与分离仍然分开操作,并没有实现连续生产。There have been many reports on the synthesis process of melatonin. Yang Jianwu et al. (Yang Jianwu, Cao Huilan. Synthesis and characterization of melatonin [J]. Chemical Research, 2003, 14 (4): 42-44.) reported a 5-methoxytryptamine as raw material, acetic anhydride Acylating reagent reacts the method for synthesizing N-acetyl-5-methoxytryptamine, and this method has problems such as acylation time is long (more than three hours), reaction speed is slower, energy consumption is big, cost is high, and is not suitable for Industrial production. Miryam Femandez-Suarez et al. (The development of integrated microfluidic chemistry platforms for lead optimization in the phar maceutical industry, Fourth international conference on Nanochannels, Microchannels and Minichannels, Miryam Femandez-Suarez, et al., Page 1-6) disclosed a The method for preparing melatonin with a microreactor, although the reaction time is reduced to 12s by using a microreactor, the synthesis and separation are still operated separately, and continuous production has not been realized.
发明人团队(CN106622070A)较早前公开了一种利用微反应器连续制备褪黑素的方法,在此基础上经过长期大量的实验和总结,本着继续优化微反应器功能的目的,进一步开发出了一种以微反应器为载体连续合成分离褪黑素的方法。该方法不仅简化了操作,更实现了不间断生产,能够在合成褪黑素的同时对其进行高效的分离提纯,工业化、自动化程度较高。The inventor team (CN106622070A) disclosed a method for continuously preparing melatonin using a microreactor earlier. On this basis, after a large number of long-term experiments and summaries, in line with the purpose of continuing to optimize the function of the microreactor, further development A method for continuous synthesis and isolation of melatonin using microreactor as a carrier was developed. The method not only simplifies the operation, but also realizes uninterrupted production, can efficiently separate and purify the melatonin while synthesizing it, and has a high degree of industrialization and automation.
发明内容Contents of the invention
本发明的目的在于克服现有褪黑素合成方法存在的反应时间长、效率低、合成与提纯分开进行、产物后处理繁琐复杂等不足,提供一种利用微反应器连续、快速合成及提纯褪黑素的方法,该方法包括以下步骤:The purpose of the present invention is to overcome the disadvantages of long reaction time, low efficiency, separate synthesis and purification, cumbersome and complicated post-treatment of the product, etc. existing in the existing melatonin synthesis method, and to provide a continuous and rapid synthesis and purification of melatonin using a microreactor. The method for melanin, the method comprises the following steps:
(a)将5-甲氧基色胺溶于二氯甲烷中,得到5-甲氧基色胺-二氯甲烷溶液;配制一定浓度的碳酸钠水溶液;(b)通过并联的微管道将5-甲氧基色胺-二氯甲烷溶液和乙酸酐按照一定比例输送进微反应器,同时将配制好的碳酸钠水溶液输送至微反应器出口处,使其与反应后的物料混合,所得混合物料进入分液装置中分液,将下层有机相输送至减压蒸馏装置中蒸馏,将蒸馏所得液体重结晶即可。(a) 5-methoxytryptamine is dissolved in dichloromethane to obtain 5-methoxytryptamine-dichloromethane solution; a certain concentration of sodium carbonate aqueous solution is prepared; The oxytryptamine-dichloromethane solution and acetic anhydride are transported into the micro-reactor according to a certain ratio, and at the same time, the prepared sodium carbonate aqueous solution is transported to the outlet of the micro-reactor to mix it with the reacted material, and the resulting mixed material enters the separation Separate the liquid in the liquid device, transport the lower organic phase to the vacuum distillation device for distillation, and recrystallize the liquid obtained from the distillation.
进一步的,5-甲氧基色胺-二氯甲烷溶液的浓度为0.025-0.1g/mL。选择二氯甲烷作为溶剂主要是利用其与水不相溶的特性便于后续分离提纯;如若选择乙醇,则后续的分离操作难以有效进行;若选择THF,则会引起管路溶胀变形,破坏微反应通道。Further, the concentration of the 5-methoxytryptamine-dichloromethane solution is 0.025-0.1 g/mL. Choosing dichloromethane as a solvent is mainly to make use of its inmiscibility with water to facilitate subsequent separation and purification; if ethanol is selected, the subsequent separation operation will be difficult to carry out effectively; if THF is selected, it will cause swelling and deformation of the pipeline and destroy micro-reactions aisle.
进一步的,所述碳酸钠水溶液的质量分数为10%-30%。Further, the mass fraction of the sodium carbonate aqueous solution is 10%-30%.
进一步的,反应时所需各物料的质量比为5-甲氧基色胺:乙酸酐:碳酸钠溶液=1:2-10:20-50。乙酸酐应过量,因此其比例较5-甲氧基色胺-二氯甲烷溶液高;为节约成本,碳酸钠溶液应适当过量(近似相当于其他两种物料的流量之和),便于淬灭过量的乙酸酐,并将反应生成的乙酸萃取到无机相中,利于反应副产物及未反应完的乙酸酐与产物分离。Further, the mass ratio of each material required for the reaction is 5-methoxytryptamine: acetic anhydride: sodium carbonate solution = 1:2-10:20-50. Acetic anhydride should be in excess, so its ratio is higher than that of 5-methoxytryptamine-dichloromethane solution; for cost saving, sodium carbonate solution should be in excess (approximately equivalent to the flow sum of the other two materials), so as to quench the excess acetic anhydride, and extract the acetic acid generated by the reaction into the inorganic phase, which is beneficial to the separation of reaction by-products and unreacted acetic anhydride from the product.
进一步的,所述微反应器为PTFE材质,其中微管长度为80-120cm。Further, the microreactor is made of PTFE, and the length of the microtube is 80-120cm.
进一步的,反应时将微反应器置于20℃水浴中,同时超声振荡处理,混合物料在微反应器中停留时间为10-90s,流速1.18-47.1mL/h。Further, during the reaction, the microreactor is placed in a water bath at 20°C, and ultrasonic vibration is performed at the same time, the residence time of the mixed material in the microreactor is 10-90s, and the flow rate is 1.18-47.1mL/h.
进一步的,减压蒸馏的真空度为0.09MPa,温度40℃,重结晶温度为-10℃。Further, the vacuum degree of vacuum distillation is 0.09MPa, the temperature is 40°C, and the recrystallization temperature is -10°C.
与现有技术相比,本发明的有益效果主要体现在以下几个方面:(1)利用二氯甲烷将原料5-甲氧基色胺溶解制成反应液,以便于其更好的与另一反应液乙酸酐充分混合反应,并且二氯甲烷毒性相对较小,还有利于产物与杂质的分离和提纯;(2)物料在微反应器中停留时间短,反应充分彻底,反应完的物料在出口处直接与碳酸钠水溶液混合萃取,整个过程更加连贯,萃取所得有机液相经减压蒸馏和结晶后即得到高纯度的褪黑素产物;(3)现有微反应器产物合成与分离提纯不能同时进行,一般需要先在微反应器中合成产物并将其收集起来,然后将收集好的产物进行下一步提纯操作,产物的合成和提纯是分开的,整个工艺并不连贯,生产效率较低。本发明成功解决了上述问题。Compared with the prior art, the beneficial effects of the present invention are mainly reflected in the following aspects: (1) utilize dichloromethane to dissolve the raw material 5-methoxytryptamine to make a reaction solution, so that it can be better combined with another The reaction solution acetic anhydride is fully mixed and reacted, and the toxicity of dichloromethane is relatively small, which is also beneficial to the separation and purification of the product and impurities; (2) the residence time of the material in the microreactor is short, the reaction is fully and completely, and the reacted material is in the microreactor. The outlet is directly mixed with sodium carbonate aqueous solution for extraction, the whole process is more coherent, and the organic liquid phase obtained after extraction is subjected to vacuum distillation and crystallization to obtain high-purity melatonin products; (3) Synthesis and separation and purification of existing microreactor products It cannot be carried out at the same time. Generally, it is necessary to synthesize the product in the microreactor and collect it, and then carry out the next purification operation on the collected product. The synthesis and purification of the product are separated, the whole process is not coherent, and the production efficiency is low. Low. The present invention successfully solves the above-mentioned problems.
附图说明Description of drawings
图1为本发明合成装置示意图。Figure 1 is a schematic diagram of the synthesis device of the present invention.
具体实施方式Detailed ways
为使本领域普通技术人员充分理解本发明的技术方案和有益效果,以下结合具体实施例进行进一步说明。In order to enable those skilled in the art to fully understand the technical solutions and beneficial effects of the present invention, further description will be given below in conjunction with specific examples.
本发明所使用的装置如图1所示,该微反应器进口处通过两条并联的管路分别与反应液A和反应液B相连,其出口处通过支路管路与溶液C相连,所有反应液都由微量输送泵精确计量输送。出口物料与溶液C混合后输送至分液装置(分液漏斗)中分液,下层有机相减压蒸馏、重结晶后即为高纯度产物。该微反应器为PTFE材质,微管长度为100cm。The device used in the present invention is shown in Figure 1, and this microreactor inlet is connected with reaction solution A and reaction solution B respectively by two parallel pipelines, and its outlet is connected with solution C by branch pipeline, all The reaction solution is accurately metered and delivered by a micro delivery pump. The outlet material is mixed with solution C and transported to a liquid separator (separating funnel) for liquid separation, and the lower organic phase is distilled under reduced pressure and recrystallized to obtain a high-purity product. The microreactor is made of PTFE, and the length of the microtube is 100cm.
实施例1Example 1
将0.3g 5-甲氧基色胺溶于6mL二氯甲烷中,得到浓度为0.050g/mL的5-甲氧基色胺-二氯甲烷溶液。将1g碳酸钠溶于9mL水中,得到质量分数为10%的碳酸钠水溶液。Dissolve 0.3 g of 5-methoxytryptamine in 6 mL of dichloromethane to obtain a 5-methoxytryptamine-dichloromethane solution with a concentration of 0.050 g/mL. Dissolve 1 g of sodium carbonate in 9 mL of water to obtain a 10% aqueous solution of sodium carbonate.
将微反应器置于20℃的水浴中,同时开启超声振荡。将5-甲氧基色胺-二氯甲烷溶液、乙酸酐通过进口管路同时泵入微反应器中,立刻将碳酸钠水溶液泵送至微反应器出口处与出口物料混合。5-甲氧基色胺-二氯甲烷溶液的流量为37.7mL/h,乙酸酐的流量为9.4mL/h,碳酸钠水溶液的流量为40mL/h,物料停留时间45s左右。The microreactor was placed in a water bath at 20 °C while ultrasonic oscillation was turned on. The 5-methoxytryptamine-dichloromethane solution and acetic anhydride are simultaneously pumped into the microreactor through the inlet pipeline, and the sodium carbonate aqueous solution is immediately pumped to the outlet of the microreactor to mix with the outlet materials. The flow rate of 5-methoxytryptamine-dichloromethane solution is 37.7mL/h, the flow rate of acetic anhydride is 9.4mL/h, the flow rate of sodium carbonate aqueous solution is 40mL/h, and the material residence time is about 45s.
从微反应器出来的物料与碳酸钠水溶液混合后进入分液漏斗,取下层二氯甲烷层进行减压蒸馏(真空度0.09MPa,水浴温度40℃,将溶剂全部蒸干)。蒸馏所得液体在-10℃重结晶,得0.30g固体。计算可知产品收率为80.61%。该固体经核磁等测试表明,的确为褪黑素。The material coming out from the microreactor is mixed with the aqueous sodium carbonate solution and enters the separatory funnel, and the lower dichloromethane layer is removed for distillation under reduced pressure (vacuum degree 0.09MPa, water bath temperature 40°C, all solvents are evaporated to dryness). The liquid obtained by distillation was recrystallized at -10°C to obtain 0.30 g of solid. Calculation shows that the product yield is 80.61%. Tests such as NMR have shown that the solid is indeed melatonin.
实施例2Example 2
将0.3g 5-甲氧基色胺溶于4mL二氯甲烷中,得到浓度为0.075g/mL的5-甲氧基色胺-二氯甲烷溶液。将1g碳酸钠溶于10mL水中,得到质量分数为10%的碳酸钠水溶液。Dissolve 0.3 g of 5-methoxytryptamine in 4 mL of dichloromethane to obtain a 5-methoxytryptamine-dichloromethane solution with a concentration of 0.075 g/mL. Dissolve 1 g of sodium carbonate in 10 mL of water to obtain a 10% aqueous solution of sodium carbonate.
将微反应器置于20℃的水浴中,同时开启超声振荡。将5-甲氧基色胺-二氯甲烷溶液、乙酸酐通过进口管路同时泵入微反应器中,立刻将碳酸钠水溶液泵送至微反应器出口处与出口物料混合。5-甲氧基色胺-二氯甲烷溶液的流量为1.06mL/h,乙酸酐的流量为0.12mL/h,碳酸钠水溶液的流量为5mL/h,物料停留时间45s左右。The microreactor was placed in a water bath at 20 °C while ultrasonic oscillation was turned on. The 5-methoxytryptamine-dichloromethane solution and acetic anhydride are simultaneously pumped into the microreactor through the inlet pipeline, and the sodium carbonate aqueous solution is immediately pumped to the outlet of the microreactor to mix with the outlet materials. The flow rate of 5-methoxytryptamine-dichloromethane solution is 1.06mL/h, the flow rate of acetic anhydride is 0.12mL/h, the flow rate of sodium carbonate aqueous solution is 5mL/h, and the material residence time is about 45s.
从微反应器出来的物料与碳酸钠水溶液混合后进入分液漏斗,取下层二氯甲烷层进行减压蒸馏(真空度0.09MPa,水浴温度40℃,将溶剂全部蒸干)。蒸馏所得液体在-10℃下重结晶,得0.28g固体。计算可知产品收率为73.7%。The material coming out from the microreactor is mixed with the aqueous sodium carbonate solution and enters the separatory funnel, and the lower dichloromethane layer is removed for distillation under reduced pressure (vacuum degree 0.09MPa, water bath temperature 40°C, all solvents are evaporated to dryness). The liquid obtained by distillation was recrystallized at -10°C to obtain 0.28 g of solid. Calculation shows that the product yield is 73.7%.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811584073.4A CN110105261A (en) | 2018-12-24 | 2018-12-24 | A method of continuous, rapid synthesis and purification epiphysin using microreactor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811584073.4A CN110105261A (en) | 2018-12-24 | 2018-12-24 | A method of continuous, rapid synthesis and purification epiphysin using microreactor |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110105261A true CN110105261A (en) | 2019-08-09 |
Family
ID=67483405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811584073.4A Pending CN110105261A (en) | 2018-12-24 | 2018-12-24 | A method of continuous, rapid synthesis and purification epiphysin using microreactor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110105261A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113230993A (en) * | 2021-05-18 | 2021-08-10 | 山东科加工业技术研究院有限公司 | Device for preparing dilute acid or mixed acid by utilizing RTB reactor, method and application thereof |
CN115650891A (en) * | 2022-10-27 | 2023-01-31 | 常熟市滨江化工有限公司 | Method for purifying tert-butyl peroxybenzoate by using microchannel reactor |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3105850A1 (en) * | 1981-02-18 | 1982-08-19 | Horst, Hans Jörg, Priv.Doz.Dr., 2057 Reinbek | Agent for treating tumours |
JPS6445361A (en) * | 1983-07-01 | 1989-02-17 | Nestle Sa | Manufacture of n-acetylserotonin |
US6436984B1 (en) * | 1998-12-18 | 2002-08-20 | Centre National De La Recherche Scientifique (Cnrs) | Melatonin derivatives and medicine containing same |
CN102329263A (en) * | 2011-10-17 | 2012-01-25 | 上海化学试剂研究所 | Preparation method of N-acetyl-5-methoxytryptamine |
CN106622070A (en) * | 2016-12-26 | 2017-05-10 | 武汉工程大学 | Method for continuously preparing melatonin by using microreactor |
-
2018
- 2018-12-24 CN CN201811584073.4A patent/CN110105261A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3105850A1 (en) * | 1981-02-18 | 1982-08-19 | Horst, Hans Jörg, Priv.Doz.Dr., 2057 Reinbek | Agent for treating tumours |
JPS6445361A (en) * | 1983-07-01 | 1989-02-17 | Nestle Sa | Manufacture of n-acetylserotonin |
US6436984B1 (en) * | 1998-12-18 | 2002-08-20 | Centre National De La Recherche Scientifique (Cnrs) | Melatonin derivatives and medicine containing same |
CN102329263A (en) * | 2011-10-17 | 2012-01-25 | 上海化学试剂研究所 | Preparation method of N-acetyl-5-methoxytryptamine |
CN106622070A (en) * | 2016-12-26 | 2017-05-10 | 武汉工程大学 | Method for continuously preparing melatonin by using microreactor |
Non-Patent Citations (2)
Title |
---|
万宁等: ""美乐托宁的合成新工艺研究"", 《西北药学杂志》 * |
杨昭等: ""美乐托宁微反应合成系统的开发"", 《武汉工程大学学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113230993A (en) * | 2021-05-18 | 2021-08-10 | 山东科加工业技术研究院有限公司 | Device for preparing dilute acid or mixed acid by utilizing RTB reactor, method and application thereof |
CN115650891A (en) * | 2022-10-27 | 2023-01-31 | 常熟市滨江化工有限公司 | Method for purifying tert-butyl peroxybenzoate by using microchannel reactor |
CN115650891B (en) * | 2022-10-27 | 2024-05-03 | 常熟市滨江化工有限公司 | Method for purifying tert-butyl peroxybenzoate by using microchannel reactor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112979461B (en) | A kind of fully continuous flow preparation method of 3-chloro-4-oxoacetate amyl | |
CN101544567B (en) | Nitration method for synthesizing dinitrotoluene in one step | |
WO2013025775A1 (en) | Process for manufacturing hmb and salts thereof | |
CN111018715A (en) | Microchannel synthesis method of dinitrobenzene | |
CN108129267B (en) | Low-temperature full-continuous reaction system and application | |
CN107266321B (en) | A kind of method of trifluoromethoxybenzene nitration | |
CN103848880B (en) | Method for preparing 9 beta, 10-alpha-dehydroprogesterone ketal by using dual-wavelength microfluidic technology and dual-wavelength microfluidic photochemical reactor | |
CN110105261A (en) | A method of continuous, rapid synthesis and purification epiphysin using microreactor | |
US11834388B2 (en) | Continuous-flow preparation method of diclofenac sodium | |
CN107253913B (en) | Method for preparing chloroenyne by using microchannel reactor | |
CN107033005B (en) | Nitration method of aromatic compound | |
CN111440215A (en) | Method for preparing Reidesvir by using microchannel reaction device | |
Sun et al. | Two-step continuous flow process of sodium tanshinone IIA sulfonate using a 3D circular cyclone-type microreactor | |
CN106622070A (en) | Method for continuously preparing melatonin by using microreactor | |
CN111302915A (en) | A kind of method for preparing anisaldehyde by microchannel continuous ozone oxidation | |
CN109422642B (en) | Refining method of benzoic acid, production method and equipment of pharmaceutical grade sodium benzoate | |
CN114349678A (en) | Continuous industrial production method of N-alkyl-nitrophthalimide | |
CN105294797A (en) | Preparation method for methyltestosterone | |
CN105111090B (en) | A kind of continuous preparation method of 1,1-diamino-2,2-dinitroethylene | |
CN101333154A (en) | Method for synthesizing beta-ionone | |
CN117884055A (en) | A continuous synthesis system and method of cumene hydroperoxide | |
CN103342647A (en) | Continuous preparation method of trinitromalonaldehydic acid dipotassium salt | |
CN114516812A (en) | Full continuous flow preparation method of levocarnitine | |
CN113121397A (en) | Method for preparing caprolactam from cyclohexanone oxime | |
CN107118174B (en) | A kind of preparation method of 3,4-dicyanofuroxan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190809 |